JP Stock MarketDetailed Quotes

4519 Chugai Pharmaceutical

Watchlist
  • 8219.0
  • +201.0+2.51%
20min DelayMarket Closed Apr 30 15:30 JST
13.80TMarket Cap34.92P/E (Static)

Chugai Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
Total revenue
21.74%288.46B
5.33%1.17T
18.13%315.91B
-24.11%236.95B
-11.78%1.11T
273.81B
14.48%257.9B
13.50%267.42B
-13.35%312.24B
26.00%1.26T
Cost of revenue
20.39%87.82B
-17.88%339.41B
-4.06%87.94B
-51.79%72.95B
-13.22%413.31B
92.06B
13.26%78.26B
14.83%91.66B
32.25%151.33B
40.84%476.25B
Gross profit
22.34%200.64B
19.07%831.2B
29.71%227.97B
1.92%164B
-10.90%698.06B
181.75B
15.02%179.64B
12.82%175.76B
-34.57%160.91B
18.42%783.48B
Operating expense
-0.22%63.99B
11.71%289.2B
10.31%69.65B
2.41%64.13B
3.49%258.89B
60.18B
23.02%72.96B
13.06%63.14B
6.30%62.62B
4.36%250.17B
Selling and administrative expenses
2.88%23.24B
-2.20%110.1B
-17.88%27.32B
7.47%22.59B
12.05%112.58B
--30.76B
15.82%27.54B
43.65%33.26B
-7.77%21.02B
-1.89%100.48B
-Selling and marketing expense
2.88%23.24B
-2.20%110.1B
-17.88%27.32B
7.47%22.59B
12.05%112.58B
--30.76B
15.82%27.54B
43.65%33.26B
-7.77%21.02B
31.18%100.48B
Research and development costs
-1.03%40.93B
3.76%181.44B
-3.66%42.94B
-3.53%41.36B
16.87%174.87B
--41.86B
24.15%45.57B
31.79%44.57B
26.58%42.87B
8.98%149.63B
Other operating expenses
-196.22%-178M
91.81%-2.34B
95.90%-603M
114.59%185M
-44,726.56%-28.56B
---12.44B
86.53%-160M
-1,203.82%-14.69B
-156.36%-1.27B
--64M
Operating profit
36.82%136.65B
23.41%542B
40.59%158.32B
1.60%99.87B
-17.65%439.17B
121.58B
10.11%106.69B
12.68%112.62B
-47.44%98.3B
26.41%533.31B
Net non-operating interest income (expenses)
-5,580.00%-822M
-77.79%1.03B
-65.22%480M
-98.90%15M
51,733.33%4.65B
1.11B
142.48%788M
78.53%1.38B
-14.63%1.37B
-132.14%-9M
Non-operating interest income
-80.00%3M
--5M
-65.44%480M
-98.90%15M
----
----
----
76.27%1.39B
-15.24%1.37B
----
Non-operating interest expense
--825M
----
----
----
-55.74%27M
--8M
-53.33%7M
-40.00%9M
-85.71%2M
27.08%61M
Total other finance cost
----
78.03%-1.03B
----
----
-8,888.46%-4.67B
---1.12B
-143.21%-795M
----
----
31.58%-52M
Net investment income
Gain(Loss) on financial instruments designated as cash flow hedges
Gain(Loss) on derecognition of available-for-sale financial assets
Income from associates and other participating interests
Special income (charges)
Other non-operating income (expenses)
15.98%-2.13B
Income before tax
35.98%135.83B
22.35%543.03B
39.31%158.8B
0.23%99.89B
-16.44%443.82B
122.69B
13.09%107.48B
13.19%113.99B
-46.48%99.66B
26.65%531.17B
Income tax
51.42%38.6B
31.57%155.72B
52.40%46.94B
-2.57%25.49B
-24.49%118.35B
31.48B
9.80%29.9B
8.70%30.8B
-51.94%26.16B
34.67%156.74B
Net income
30.69%97.23B
19.00%387.32B
34.46%111.86B
1.23%74.4B
-13.08%325.47B
91.21B
14.42%77.57B
14.94%83.19B
-44.22%73.5B
23.58%374.43B
Net income continuous operations
30.69%97.23B
19.00%387.32B
34.46%111.86B
1.23%74.4B
-13.08%325.47B
--91.21B
14.42%77.57B
14.94%83.19B
-44.22%73.5B
23.58%374.43B
Noncontrolling interests
Net income attributable to the company
30.69%97.23B
19.00%387.32B
34.46%111.86B
1.23%74.4B
-13.08%325.47B
91.21B
14.42%77.57B
14.94%83.19B
-44.22%73.5B
23.58%374.43B
Preferred stock dividends
Other under preferred stock dividend
0
0
0
0
0
0
0
0
0
0
Net income attributable to common stockholders
30.69%97.23B
19.00%387.32B
34.46%111.86B
1.23%74.4B
-13.08%325.47B
91.21B
14.42%77.57B
14.94%83.19B
-44.22%73.5B
23.58%374.43B
Gross dividend payment
Basic earnings per share
30.67%59.09
18.99%235.39
34.43%67.98
1.21%45.22
-13.10%197.83
55.43
14.41%47.15
14.93%50.57
-44.25%44.68
23.52%227.64
Diluted earnings per share
30.68%59.08
18.99%235.36
34.43%67.97
1.21%45.21
-13.08%197.8
55.43
14.42%47.14
14.94%50.56
-44.23%44.67
23.57%227.57
Dividend per share
0
22.50%98
2.50%41
0
2.56%80
40
0
5.26%40
0
2.63%78
Currency Unit
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
Accounting Standards
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022
Total revenue 21.74%288.46B5.33%1.17T18.13%315.91B-24.11%236.95B-11.78%1.11T273.81B14.48%257.9B13.50%267.42B-13.35%312.24B26.00%1.26T
Cost of revenue 20.39%87.82B-17.88%339.41B-4.06%87.94B-51.79%72.95B-13.22%413.31B92.06B13.26%78.26B14.83%91.66B32.25%151.33B40.84%476.25B
Gross profit 22.34%200.64B19.07%831.2B29.71%227.97B1.92%164B-10.90%698.06B181.75B15.02%179.64B12.82%175.76B-34.57%160.91B18.42%783.48B
Operating expense -0.22%63.99B11.71%289.2B10.31%69.65B2.41%64.13B3.49%258.89B60.18B23.02%72.96B13.06%63.14B6.30%62.62B4.36%250.17B
Selling and administrative expenses 2.88%23.24B-2.20%110.1B-17.88%27.32B7.47%22.59B12.05%112.58B--30.76B15.82%27.54B43.65%33.26B-7.77%21.02B-1.89%100.48B
-Selling and marketing expense 2.88%23.24B-2.20%110.1B-17.88%27.32B7.47%22.59B12.05%112.58B--30.76B15.82%27.54B43.65%33.26B-7.77%21.02B31.18%100.48B
Research and development costs -1.03%40.93B3.76%181.44B-3.66%42.94B-3.53%41.36B16.87%174.87B--41.86B24.15%45.57B31.79%44.57B26.58%42.87B8.98%149.63B
Other operating expenses -196.22%-178M91.81%-2.34B95.90%-603M114.59%185M-44,726.56%-28.56B---12.44B86.53%-160M-1,203.82%-14.69B-156.36%-1.27B--64M
Operating profit 36.82%136.65B23.41%542B40.59%158.32B1.60%99.87B-17.65%439.17B121.58B10.11%106.69B12.68%112.62B-47.44%98.3B26.41%533.31B
Net non-operating interest income (expenses) -5,580.00%-822M-77.79%1.03B-65.22%480M-98.90%15M51,733.33%4.65B1.11B142.48%788M78.53%1.38B-14.63%1.37B-132.14%-9M
Non-operating interest income -80.00%3M--5M-65.44%480M-98.90%15M------------76.27%1.39B-15.24%1.37B----
Non-operating interest expense --825M-------------55.74%27M--8M-53.33%7M-40.00%9M-85.71%2M27.08%61M
Total other finance cost ----78.03%-1.03B---------8,888.46%-4.67B---1.12B-143.21%-795M--------31.58%-52M
Net investment income
Gain(Loss) on financial instruments designated as cash flow hedges
Gain(Loss) on derecognition of available-for-sale financial assets
Income from associates and other participating interests
Special income (charges)
Other non-operating income (expenses) 15.98%-2.13B
Income before tax 35.98%135.83B22.35%543.03B39.31%158.8B0.23%99.89B-16.44%443.82B122.69B13.09%107.48B13.19%113.99B-46.48%99.66B26.65%531.17B
Income tax 51.42%38.6B31.57%155.72B52.40%46.94B-2.57%25.49B-24.49%118.35B31.48B9.80%29.9B8.70%30.8B-51.94%26.16B34.67%156.74B
Net income 30.69%97.23B19.00%387.32B34.46%111.86B1.23%74.4B-13.08%325.47B91.21B14.42%77.57B14.94%83.19B-44.22%73.5B23.58%374.43B
Net income continuous operations 30.69%97.23B19.00%387.32B34.46%111.86B1.23%74.4B-13.08%325.47B--91.21B14.42%77.57B14.94%83.19B-44.22%73.5B23.58%374.43B
Noncontrolling interests
Net income attributable to the company 30.69%97.23B19.00%387.32B34.46%111.86B1.23%74.4B-13.08%325.47B91.21B14.42%77.57B14.94%83.19B-44.22%73.5B23.58%374.43B
Preferred stock dividends
Other under preferred stock dividend 0000000000
Net income attributable to common stockholders 30.69%97.23B19.00%387.32B34.46%111.86B1.23%74.4B-13.08%325.47B91.21B14.42%77.57B14.94%83.19B-44.22%73.5B23.58%374.43B
Gross dividend payment
Basic earnings per share 30.67%59.0918.99%235.3934.43%67.981.21%45.22-13.10%197.8355.4314.41%47.1514.93%50.57-44.25%44.6823.52%227.64
Diluted earnings per share 30.68%59.0818.99%235.3634.43%67.971.21%45.21-13.08%197.855.4314.42%47.1414.94%50.56-44.23%44.6723.57%227.57
Dividend per share 022.50%982.50%4102.56%804005.26%4002.63%78
Currency Unit JPYJPYJPYJPYJPYJPYJPYJPYJPYJPY
Accounting Standards NonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAP

Market Insights

Warren Buffett Portfolio Warren Buffett Portfolio

Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry. Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry.

No. Symbol 5D % Chg
Sample Name
Sample Code
 +16.60%
Sample Name
Sample Code
 +12.21%
Sample Name
Sample Code
 +10.90%
4
Jefferies Financial
JEF
+8.50%
5
Amazon
AMZN
+8.21%
Unlock Now

Discussing

2025 Buffett shareholders' meeting: What's the new buzz in value investing?
🎙️Discussion 1. In the face of market changes, do you prefer to stick with growth stocks or switch to value stocks? 2. Based on the current Show More
Warren Buffett Stands Tall as U.S. Stocks Tumble: How the 'Oracle' Is Tackling Tariff Impacts

Investment Course

How to Buy Stocks for Beginners
Learn stock market basics and confidently start investing with our beginner-friendly guide to buying stocks. Start your investment journey today!
What Is Options Trading and How to Trade Options
Options trading is carried out by all kinds of investors within individual investment portfolios. Learn how you can put options to work within your own portfolio.
What To Know About Margin Accounts
Discover the essentials of margin accounts, including their benefits, risks, and how to use them effectively in your trading strategy.
Cash Accounts - Covering the Basics
Discover the essentials of cash accounts. Learn what cash accounts are, how they function, their potential benefits, and the differences between cash and margin accounts.
Understanding Fractional Shares: A Beginner's Guide
Discover the basics of fractional shares, how they work, and the process for buying and selling them.

- No more -